3 min read

UBC Appoints Bekki Brown President & Chief Executive Officer

Effective January 1, 2023, Bekki Brown, COO of UBC, will be elevated to the role of President & Chief Executive Officer of UBC.
Effective January 1, 2023, Bekki Brown, COO of UBC, will be elevated to the role of President & Chief Executive Officer of UBC.

BLUE BELL, P.A., November 10, 2022 – UBC, a biopharmaceutical leader providing integrated clinical, safety, and commercialization services, announced today that effective January 1, 2023, Bekki Brown, UBC’s Chief Operating Officer, will be elevated to the role of President & Chief Executive Officer.

Bekki’s more than 20 years of senior management experience focused on strategic growth and operational excellence for industry-leading organizations such as Quintiles, INC Research, and Syneos Health, will play an integral role in designing UBC’s long-term market position, expanding their service model, and maintaining their financial strength.

“As we enter the post-COVID world of drug development, we embark on one of the most innovative markets in recent history,” said Patrick Lindsay, President & Chief Executive Officer, UBC. “To best maximize our opportunities, we are now positioning UBC for significant growth, both organically and inorganically. I have the utmost confidence that Bekki will provide the vision, leadership, and management necessary to ensure UBC remains a standard bearer for innovation, quality, and safety in the life sciences industry as we continue to adapt, evolve, and grow.”

In the new year, Mr. Lindsay will join the UBC Board of Directors serving as strategic advisor to the CEO, and the organization, in achieving purposeful growth with a keen focus on identifying inorganic opportunities that support the strategic direction of UBC.

About UBC

United BioSource LLC (UBC) is a leader in the biopharmaceutical market that provides integrated clinical, safety, and commercialization services. UBC brings together renowned scientific research and operations experts with innovative technologies, allowing for the best patient and healthcare provider experience. Comprehensive, end-to-end services cover product and patient population characterization during development and market entry, as well as a focus on the patient experience, safety, and adherence. For additional information, visit www.ubc.com.

Media Inquiries

Amber Frasketi

UBC

Phone: 215.588.8423

Email: amber.frasketi@ubc.com

Other Recent Posts

Press
5 min read

UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation

This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.
Press
3 min read

UBC Appoints Anthony Luttenberger Chief Commercial Officer

Biopharma services industry veteran brings decades of experience spanning late-stage, clinical trials, & post-approval commercial support.
Press
1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.
UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.